- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting CD276 for T cell-based immunotherapy of breast cancer ; volume:22 ; number:1 ; day:4 ; month:10 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (4.10.2024), 1-15, 12.2024
- Urheber
-
Hagelstein, Ilona
Wessling, Laura
Rochwarger, Alexander
Zekri, Latifa
Klimovich, Boris
Tegeler, Christian M.
Jung, Gundram
Schürch, Christian M.
Salih, Helmut R.
Lutz, Martina S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05689-4
- URN
-
urn:nbn:de:101:1-2412202112418.075797395289
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hagelstein, Ilona
- Wessling, Laura
- Rochwarger, Alexander
- Zekri, Latifa
- Klimovich, Boris
- Tegeler, Christian M.
- Jung, Gundram
- Schürch, Christian M.
- Salih, Helmut R.
- Lutz, Martina S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells